139 related articles for article (PubMed ID: 25687869)
1. Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009.
Shin SH; Jung KW; Ha J; Lee SH; Won YJ; Yoo H
Cancer Res Treat; 2015 Oct; 47(4):569-74. PubMed ID: 25687869
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
5. Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012.
Lee SH; Jung KW; Ha J; Oh CM; Kim H; Park HJ; Yoo H; Won YJ
Cancer Res Treat; 2017 Apr; 49(2):494-501. PubMed ID: 27554477
[TBL] [Abstract][Full Text] [Related]
6. A Nationwide, Population-Based Epidemiologic Study of Childhood Brain Tumors in Korea, 2005-2014: A Comparison with United States Data.
Kang JM; Ha J; Hong EK; Ju HY; Park BK; Shin SH; Won YJ; Jung KW; Park HJ
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):409-416. PubMed ID: 30348678
[TBL] [Abstract][Full Text] [Related]
7. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.
Villano JL; Koshy M; Shaikh H; Dolecek TA; McCarthy BJ
Br J Cancer; 2011 Oct; 105(9):1414-8. PubMed ID: 21915121
[TBL] [Abstract][Full Text] [Related]
8. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database.
Shin A; Won YJ; Jung HK; Kong HJ; Jung KW; Oh CM; Choe S; Lee J
J Gastroenterol Hepatol; 2018 Dec; 33(12):1961-1968. PubMed ID: 29802647
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
10. Population-based survival data for brain tumors in Korea.
Jung KW; Yoo H; Kong HJ; Won YJ; Park S; Lee SH
J Neurooncol; 2012 Sep; 109(2):301-7. PubMed ID: 22660961
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Survival of Childhood Cancer in Korea.
Park HJ; Moon EK; Yoon JY; Oh CM; Jung KW; Park BK; Shin HY; Won YJ
Cancer Res Treat; 2016 Jul; 48(3):869-82. PubMed ID: 26790965
[TBL] [Abstract][Full Text] [Related]
12. Trends in primary central nervous system lymphoma incidence and survival in the U.S.
Shiels MS; Pfeiffer RM; Besson C; Clarke CA; Morton LM; Nogueira L; Pawlish K; Yanik EL; Suneja G; Engels EA
Br J Haematol; 2016 Aug; 174(3):417-24. PubMed ID: 27018254
[TBL] [Abstract][Full Text] [Related]
13. Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996.
Hao D; DiFrancesco LM; Brasher PM; deMetz C; Fulton DS; DeAngelis LM; Forsyth PA
Ann Oncol; 1999 Jan; 10(1):65-70. PubMed ID: 10076724
[TBL] [Abstract][Full Text] [Related]
14. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017.
Hong S; Won YJ; Park YR; Jung KW; Kong HJ; Lee ES;
Cancer Res Treat; 2020 Apr; 52(2):335-350. PubMed ID: 32178489
[TBL] [Abstract][Full Text] [Related]
15. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
[TBL] [Abstract][Full Text] [Related]
16. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma in the United States, 1975-2017.
Lv C; Wang J; Zhou M; Xu JY; Chen B; Wan Y
Ther Adv Hematol; 2022; 13():20406207211066166. PubMed ID: 35096360
[TBL] [Abstract][Full Text] [Related]
18. Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.
Eloranta S; Brånvall E; Celsing F; Papworth K; Ljungqvist M; Enblad G; Ekström-Smedby K
Eur J Haematol; 2018 Jan; 100(1):61-68. PubMed ID: 28983970
[TBL] [Abstract][Full Text] [Related]
19. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Ostrom QT; Cioffi G; Gittleman H; Patil N; Waite K; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2019 Nov; 21(Suppl 5):v1-v100. PubMed ID: 31675094
[TBL] [Abstract][Full Text] [Related]
20. The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
Mendez JS; Ostrom QT; Gittleman H; Kruchko C; DeAngelis LM; Barnholtz-Sloan JS; Grommes C
Neuro Oncol; 2018 Apr; 20(5):687-694. PubMed ID: 29036697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]